Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award COO and CFO acquired 79,113 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Exercise or conversion CEO acquired 20,000 shares (option exercise)
  5. 4 Exercise or conversion COO and CFO acquired 7,500 shares (option exercise)
  6. 4/A Open-market buy Director bought 50,000 shares at $1.56 ($78,185)
  7. 4 Open-market buy Director bought 50,000 shares at $1.56 ($78,185)
  8. 4 Open-market buy CEO and Director bought 20,000 shares at $1.55 ($31,000)
  9. 4 Open-market buy Director bought 50,000 shares at an average $1.42 ($71,228)
  10. 4 Open-market sale 10% owner sold 1,300,000 shares at $1.40 ($1,820,000)
  11. 3/A Insider 3/A
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 24 · 475 filings